WebCristina DEVIZZI(PARIS). Découvrez ses expériences et son réseau professionnel comme Zouheir MAZOULI... WebJul 1, 2000 · Gemcitabine was shown to be active in heavily pretreated patients with Hodgkin's disease, producing a response rate of 39%. PURPOSE To explore the use of gemcitabine for the treatment of patients with relapsing or refractory Hodgkin's disease. PATIENTS AND METHODS Eligible patients had measurable disease and more than …
Gemcitabine in the treatment of refractory Hodgkin
WebCristiano Rizzi specializes in energy and infrastructure capital projects. Cristiano is well-versed in critical topics affecting the entire energy value chain (from upstream to … WebGemcitabine in the treatment of refractory Hodgkin's disease: Results of a multicenter phase II study exterior wood white paint
Enrico Derenzini — Italian Ministry of Health
WebLiliana Devizzi, Carmelo Carlo-Stella, Carlo Chiesa, Emilio Bombardieri, Alessandro M. Gianni. Fondazione IRCCS Istituto Nazionale dei Tumori; Istituto Clinico Humanitas; Research output: Contribution to journal › Article › peer-review. Overview; Original language: English: Pages (from-to) 1146-1147: Number of pages: 2: WebLilians Devizzi Fondazione IRCCS Istituto Nazionale dei Tumori di Milano Istituto Tumori di Milano · Dipartimento di Ematologia Medical Oncology Contact Connect with experts in your field Join... WebLiliana Devizzi — Italian Ministry of Health View Scopus Profile Liliana Devizzi Fondazione IRCCS Istituto Nazionale dei Tumori Email lilli.devizzi @istitutotumori.mi .it 1992 … 2024 Research activity per year Overview Fingerprint Network Research output (79) Similar Profiles (1) If you made any changes in Pure these will be visible here soon. exteris bayer